| |
 |
SYM |
Description |
 |
|
CEMI |
Advanced diagnostic tests for the detection of infectious diseases, including HIV and tuberculosis
|
 |
|
|
|
|
|
|
|
Private |
Products and testing services for complex diagnostics. |
|
|
|
|
|
|
|
|
CRA |
Molecular diagnostics for infectious disease testing and genetic conditions such as cystic fibrosis. |
|
|
|
|
|
|
|
|
Private |
Develops and manufactures reagants for tests for infectious disease agents. |
|
|
|
|
|
|
|
|
Private |
Monoclonal antibodies and diagnostic assays for cancer and infectious disease. |
|
|
|
|
|
|
|
|
Private |
Diagnostic and therapeutic products for tuberculosis. |
|
|
|
|
|
|
|
|
Private |
Hygiene-monitoring products. |
|
|
|
|
|
|
|
|
Private |
In vitro diagnostic test kits. |
|
|
|
|
|
|
|
|
Private |
Infectious disease diagnostics. |
|
|
|
|
|
|
|
FASgen |
|
Baltimore, Maryland |
USA |
|
Private |
Small molecule therapeutics and diagnostics. |
|
|
|
|
|
|
|
|
Private |
Molecular diagnosis of infectious diseases and genetic profiling arrays. |
|
|
|
|
|
|
|
|
BNC |
Product for the human and animal health markets. |
|
|
|
|
|
|
|
Binax |
|
Scarborough, ME |
USA |
|
Private |
Diagnostic tools for pathogen identification. |
|
|
|
|
|
|
|
|
Private |
Diagnosis and prevention of infectious diseases. |
|
|
|
|
|
|
|
|
SSUR |
A self-contained, rapid whole-blood testing format for the detection of antibodies. |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical company that focuses on Cardiology, Dermatology, Immunology, Infectious Disease and Urology. |
|
|
|
|
|
|
|
|
Private |
Antibodies for cancer, neovascular, inflammatory and infectious diseases. |
|
|
|
|
|
|
|
|
Private |
In vitro diagnostic products for the assessment of immunity. |
|
|
|
|
|
|
|
|
Private |
Human antibody therapeutics for infectious diseases, autoimmunce disorders, and cancer. |
|
|
|
|
|
|
|
|
Private |
Drug delivery systems for animal health and lives. |
|
|
|
|
|
|
|
|
Private |
Small-molecule drugs for post-transcriptional control mechanisms. |
|
|
|
|
|
|
|
|
Private |
Biomarker assay development and commercialization. |
|
|
|
|
|
|
|
|
Private |
Drug development services for biotechnology and pharmaceutical companies. |
|
|
|
|
|
|
|
|
Private |
Pre-clinical discovery and development. |
|
|
|
|
|
|
|
|
Private |
Clinical research services for pharmaceutical, biotechnology, and medical device industries. |
|
|
|
|
|
|
|
|
Private |
Contract research for clinical trials. |
|
|
|
|
|
|
|
|
CHR |
Immune and gene-based cell therapies and cell lines for biopharmaceutical production. |
|
|
|
|
|
|
|
|
Private |
Human protein pharmaceuticals from protein engineering technologies. |
|
|
|
|
|
|
|
|
Private |
Therapeutic products for treating fibrosis, infectious disease, and cancers. |
|
|
|
|
|
|
|
|
ALRX |
Therapeutic products using proprietary drug delivery technology.
|
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
